why biotechs need to worry about generics, too, page-12

Here is a point or two for you to consider...

The device is prefill, so the total cost is made up of the drug and the device. Last time i looked the average prefill with drug was $17 over a few billion doses. The 85c that makes up our part is only 5% of the total cost.

So why the device.......

If our device is say double what a current prefill syringe is plus the add on safety device (I doubt it) then we add only 2% to the total cost.

What do you get......

A fully integrated safety device
Fits your existing fill lines
70% less storage (refrigerated is expensive)
70% less shipping
Less waste
Meets best in class status for safety

Ohh yeah

That $2 bn blockbuster drug you had that is now competing against generics, instead of sales dropping to $500M our new device helps keep the sales up at $1B....... Thats a nice little earner for 2% extra cost.

Anyway back to lurk in the shadows !!! LOL

If you build it they will come............................